2 years ago
VKTX
AnalystsRoger SongRoger Song's Stock Forecasts
AnalystsRoger Song
Analyst Ranking
Bottom 12%
#4446 out of 5014 analysts
Average Return
-1.75%
Win Rate
41%19 out of 46
Risk vs Reward
Poor
Good
Roger Song's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | +425.42% | $9.27 | $48.68 | 2025-04-10 - 2025-09-12 | Strong Buy |
Atyr Pharma IncATYR | +212.57% | $1.75 | $5.47 | 2024-09-04 - 2025-09-04 | Strong Buy |
Replimune Group IncREPL | +104.28% | $2.81 | $5.73 | 2025-07-21 - 2025-09-12 | Strong Buy |
Sutro Biopharma IncSTRO | +92.81% | $11.27 | $21.72 | 2020-09-01 - 2021-08-31 | Strong Buy |
Kinnate Biopharma IncKNTE | +76.67% | $1.50 | $2.65 | 2023-09-18 - 2024-04-02 | Strong Buy |
Roger Song Analyst Color
Get additional color on Roger Song's coverage of popular stocks
Roger Song's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tourmaline Bio IncTRML | 3 | Hold | $47.50 | -0.23% | Downgrades | 4 days ago |
United Therapeutics CorpUTHR | 1 | Strong Buy | $564.00 | +39.25% | Maintains | 11 days ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $5.00 | +159.07% | Initiates Coverage On | 16 days ago |
Atyr Pharma IncATYR | 2 | Strong Buy | $17.00 | +181.92% | Maintains | 22 days ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $36.00 | +232.41% | Assumes | a month ago |
Lava Therapeutics NvLVTX | 1 | Hold | $1.50 | -2.91% | Downgrades | a month ago |
Kiniksa Pharmaceuticals International PLCKNSA | 3 | Strong Buy | $54.00 | +45.55% | Maintains | a month ago |
Replimune Group IncREPL | 2 | Strong Buy | $6.00 | +4.71% | Maintains | 2 months ago |
Verve Therapeutics IncVERV | 1 | Hold | $11.00 | -1.17% | Downgrades | 3 months ago |
Curevac NvCVAC | 1 | Hold | $5.00 | -6.37% | Downgrades | 3 months ago |
Nektar TherapeuticsNKTR | 10 | Strong Buy | $30.00 | -38.37% | Upgrades | 5 months ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $6.00 | +103.39% | Initiates Coverage On | 5 months ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $7.00 | +117.39% | Initiates Coverage On | 6 months ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $245.00 | +70.52% | Initiates Coverage On | 6 months ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $26.00 | +273.03% | Initiates Coverage On | 7 months ago |
Igm Biosciences IncIGMS | 2 | Hold | $2.00 | +57.48% | Downgrades | 8 months ago |
Bioage Labs IncBIOA | 2 | Hold | $7.00 | +45.83% | Downgrades | 9 months ago |
Kura Oncology IncKURA | 2 | Strong Buy | $28.00 | +241.88% | Maintains | 10 months ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $7.00 | +258.97% | Upgrades | 10 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +48.78% | Initiates Coverage On | a year ago |
Novavax IncNVAX | 2 | Strong Buy | $25.00 | +213.28% | Maintains | a year ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $41.00 | +353.54% | Initiates Coverage On | a year ago |
Zenas Biopharma IncZBIO | 1 | Strong Buy | $35.00 | +73.01% | Initiates Coverage On | a year ago |
Vaxcyte IncPCVX | 1 | Strong Buy | $129.00 | N/A | Maintains | a year ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Buy | $8.00 | N/A | Upgrades | a year ago |
Nuvalent IncNUVL | 1 | Strong Buy | $97.00 | N/A | Initiates Coverage On | a year ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 2 years ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $2.00 | N/A | Maintains | 2 years ago |
Altimmune IncALT | 1 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Prelude Therapeutics IncPRLD | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Whitehawk Therapeutics IncWHWK | 1 | Strong Buy | $675.00 | N/A | Initiates Coverage On | 4 years ago |
Corvus Pharmaceuticals IncCRVS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Crescent Biopharma IncCBIO | 1 | Strong Buy | $4.00 | N/A | Upgrades | 4 years ago |
Atreca IncBCEL | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $315.00 | N/A | Initiates Coverage On | 5 years ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.